{
  "ticker": "LLY",
  "target_date": "2025-02-13",
  "actual_date": "2025-02-13",
  "collected_at": "2025-12-08T11:24:09.719141",
  "price": {
    "open": 870.58,
    "high": 876.96,
    "low": 861.38,
    "close": 865.4050903320312,
    "volume": 2472900,
    "change_1d_pct": -0.13,
    "change_7d_pct": 5.54,
    "change_30d_pct": 12.67
  },
  "technicals": {
    "rsi_14": 79.0,
    "sma_20": 808.43,
    "sma_50": 791.95,
    "macd": 25.69,
    "macd_signal": 19.289,
    "macd_histogram": 6.401,
    "bb_upper": 903.73,
    "bb_lower": 713.14,
    "price_vs_sma20_pct": 7.05,
    "price_vs_sma50_pct": 9.28,
    "volume_ratio": 0.69
  },
  "fundamentals": {
    "market_cap": 890841989120,
    "pe_ratio": 48.688717,
    "forward_pe": 43.854225,
    "price_to_book": 37.414787,
    "price_to_sales": 14.992343,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.63,
    "pct_from_52w_low": 59.31
  },
  "macro": {
    "spy": {
      "price": 604.43,
      "change_1d_pct": 1.06,
      "change_7d_pct": 0.91
    },
    "vix": {
      "level": 15.1,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.53
    },
    "dollar_index": {
      "level": 107.31
    },
    "gold": {
      "price": 2925.9
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q4 2024 Update",
      "source": "SeekingAlpha",
      "datetime": 1739486426,
      "summary": "GMO's portfolio update highlights key stock adjustments and forecasts a promising 9.6% return for International Deep Value assets. See more here.",
      "url": "https://finnhub.io/api/news?id=7fee116fab786340e0e08cc4d8e405c129a8999c0cd921f1dac302c5b6a50dcf"
    },
    {
      "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1739480280,
      "summary": "The Portfolio returned -10.75% (gross) and the MSCI World Health Care IndexSM returned -11.32%. Read more here.",
      "url": "https://finnhub.io/api/news?id=8d306981723ae6baaa27a41df72a2ad77528d2ff9fae45eee20d34b6483d2dcd"
    },
    {
      "headline": "West Pharma\u2019s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin",
      "source": "MarketWatch",
      "datetime": 1739454540,
      "summary": "West Pharma\u2019s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin",
      "url": "https://finnhub.io/api/news?id=d090434d9145d8bc6c7b2485a72cfc0e56241a5d5fcca410e8087cbd08c506bb"
    },
    {
      "headline": "Janus Henderson Global Life Sciences Fund Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1739392800,
      "summary": "The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=10b10afe2a805029d7ce2f9c8b1ec10ce14300270ce9d50ee7971586c5474449"
    },
    {
      "headline": "Aclaris Therapeutics: History Of Failures, And Recent Acquisition Of A 'Blockbuster Potential' Molecule",
      "source": "SeekingAlpha",
      "datetime": 1739257758,
      "summary": "Aclaris stock plummets 70% since Sep 2023. Promising ATI-045 results spark debate; past failures fuel skepticism.",
      "url": "https://finnhub.io/api/news?id=02e01fac1aeb6a9f9799855f17e8617b438dd8b0cdd4df9cd2289c11ecf5cec9"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739395815.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000061/xslF345X05/wk-form4_1739395815.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739395756.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000059/xslF345X05/wk-form4_1739395756.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739395681.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000057/xslF345X05/wk-form4_1739395681.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739395622.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000055/xslF345X05/wk-form4_1739395622.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739395561.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000053/xslF345X05/wk-form4_1739395561.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}